![]() PMV Pharma PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. | |||
Founding Date | Founding Date 2011 | Founding Date 2013 | Founding Date 2012 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Seongnam-si, KR HQ | Locations Cranbury Township, US HQ | Locations Cambridge, US HQ |
Employees | Employees 1285% increase | Employees 642% increase | Employees 244% decrease |
Financial | |||
Net income | Net income ₩143.2b (FY, 2024) | Net income ($77.7m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 236m | Total funding raised $ 36m |

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
View company
Portal Instruments is a development stage, venture-backed company
View company